First Light Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

First Light Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25,630	Closed	-$366K	–	79
2023 Q4	$366K	Hold	25,630	–	–	0.03%	59
2023 Q3	$396K	Hold	25,630	–	–	0.04%	52
2023 Q2	$403K	Hold	25,630	–	–	0.03%	55
2023 Q1	$422K	Hold	25,630	–	–	0.04%	47
2022 Q4	$400K	Hold	25,630	–	–	0.04%	51
2022 Q3	$332K	Hold	25,630	–	–	0.03%	63
2022 Q2	$360K	Hold	25,630	–	–	0.04%	68
2022 Q1	$367K	Hold	25,630	–	–	0.03%	73
2021 Q4	$349K	Hold	25,630	–	–	0.03%	76
2021 Q3	$420K	Hold	25,630	–	–	0.03%	74
2021 Q2	$431K	Buy	+25,630	New	+$436K	0.03%	70
2019 Q4	–	Sell	-283,200	Closed	-$4.87M	–	72
2019 Q3	$4.87M	Sell	283,200 -131,427	-32%	-$2.27M	0.74%	36
2019 Q2	$7.34M	Buy	414,627 +1,491	+0.4%	+$27.1K	1.02%	31
2019 Q1	$8.42M	Buy	+413,136	New	+$8.31M	1.09%	27

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Light Asset Management's TAK Position: Q1 2024 in Review

First Light Asset Management sold out of Takeda Pharmaceutical (TAK) in Q1 2024, closing a stake of 25,630 shares — an estimated $366K sold.

First Light Asset Management first reported a position in TAK in Q1 2019 and held it in 14 quarters. The position peaked at $8.42M in Q1 2019. 314 funds tracked by Wall St. Rank hold TAK as of Q1 2024.

First Light Asset Management reported no remaining Takeda Pharmaceutical position as of Q1 2024 after selling out during the quarter.
First Light Asset Management sold 25,630 Takeda Pharmaceutical shares in Q1 2024, an estimated $366K.
First Light Asset Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 14 quarters.
First Light Asset Management's Takeda Pharmaceutical position peaked at $8.42M in Q1 2019.
314 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2024.

Based on First Light Asset Management's 13F filing for Q1 2024, filed 15 May 2024.